Chemicals and pharmaceuticals · XOMA

XOMA Corp

12 filings mentioning 10 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
10topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

Across 12 filings we hold, XOMA Corp has written down 10 of the topics we track. That places it 29 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

TopicFilingsMost recent
Internal Control102026-04-27
Consent Order62026-02-09
Enforcement Action62026-02-09
Data Governance42023-11-07
Material Weakness42025-10-03
Restatement42026-05-22
Regulatory Reporting12020-05-05
Business Continuity12022-03-08
Data Breach12026-04-27
Ransomware12026-04-27

When it filed

Filings we hold, by year. Hover a bar for the count.

20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-05-228-KDirector or officer departure, Item 5.03, Shareholder votefiling
2026-04-278-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2026-02-098-KCompletion of an acquisition, Other material event, Financial statements and exhibitsfiling
2025-12-058-KCompletion of an acquisition, Other material event, Financial statements and exhibitsfiling
2025-10-038-KEntry into a material agreement, Financial statements and exhibitsfiling
2025-09-238-KCompletion of an acquisition, Other material event, Financial statements and exhibitsfiling
2025-08-158-KCompletion of an acquisition, Other material event, Financial statements and exhibitsfiling
2025-02-118-K/AFinancial statements and exhibitsfiling
2024-04-038-KCompletion of an acquisition, Other material event, Financial statements and exhibitsfiling
2024-02-168-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2024-01-118-KDirector or officer departure, Regulation FD disclosurefiling
2023-12-198-KEntry into a material agreement, Item 2.03, Item 3.02filing

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKO HEALTH, INC.12compare →
FIBROGEN INC12compare →
PALATIN TECHNOLOGIES INC12compare →
Oncotelic Therapeutics, Inc.12compare →
NEKTAR THERAPEUTICS12compare →
ALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition